What should I do about delays in my cancer treatment?

As hospitals and health care providers across the country continue to mobilize their resources to respond to and contain the COVID-19 outbreak, many cancer patients are worried about how their treatments may be impacted. Some hospitals are having to make difficult decisions, postponing or canceling surgeries and other procedures to make room for an influx of COVID-19 patients. Some cancer patients have already had to adjust to or work around delays in their care. Others worry that their upcoming procedures will be canceled or postponed. To help you navigate the road ahead, Sean Cavanaugh, MD, Chair of the Department of Radiation Oncology at Cancer Treatment Centers of America® (CTCA), answers common questions we’ve been fielding from cancer patients around the United States.

For more information, click here.

Topics: |

PCG Welcomes Inova Center to Our Membership!

Inova Center for Advanced Radiation Oncology and Proton Therapy

Radiation therapy is a unique treatment that uses different forms of radiation to target cancer cells. Many cancer patients will undergo some form of radiation either as a stand-alone treatment or in combination with surgery and chemotherapy.

The Inova Center for Advanced Radiation Oncology and Proton therapy offers:

  • The most advanced radiation equipment in the Washington DC region
  • Experience and clinical knowledge from a team of specialists
  • Interaction with a patient’s entire cancer care team – surgeons, medical oncologists, nurses, genetic counselors – to provide the best, and most personalized, treatment plan

Our renowned specialists use the latest techniques and technology to ensure the highest level of care is provided to patients.

To learn more, click here.

Topics: |

Annual Survey Shows Surge in Proton Therapy Treatment

Over the past four years, the number of proton therapy centers has doubled, and a growing number of patients are being treated for an increasing variety of cancers.  A recently completed survey of proton therapy centers in the U.S., shows that the annual number of patients treated with proton therapy has increased significantly from when the survey was first launched in 2012.   The number of patients treated in 2016 was 70% higher than the number of patients treated in the first survey completed in 2012.  In that time, the number of centers offering proton therapy has more than doubled, reflecting the growing knowledge among patients and healthcare providers of the clinical benefits of proton therapy.

To read the entire press release, click here.

Topics: |

PCG Welcomes Provision CARES Proton Therapy Knoxville To Our Membership!

PCG welcomes Provision CARES Proton Therapy Knoxville to our membership!
Provision CARES Proton Therapy Knoxville opened its doors to patients on January 20th 2014. They are the 13th proton center in the United States, the second in the southeast, and the first in the state of Tennessee. We are thrilled to be working with a proton center recognized in the industry for innovative treatment protocols!
Click below to learn more about the center:

Topics: |

PCG Member Spotlight: Shaakir Hasan, DO, New York Proton Center

Dr. Shaakir Hasan is an attending radiation oncologist at New York Proton Center.   He subspecializes in proton therapy for genitourinary (GU) and prostate cancers, lymphoma, and pediatric malignancies. He has authored over 50 peer-reviewed publications in the oncology space and has presented his research at multiple international conferences.

Dr. Hasan completed his undergraduate degree at University of Michigan and received his Doctor of Osteopathic Medicine from Nova Southeastern University in Fort Lauderdale, Florida, where he was awarded membership in the National Scholastic Honor Society. He completed his internship at Crozer Keystone in Philadelphia and his residency training in radiation oncology at Allegheny Health Network in Pittsburgh, Pennsylvania where he served as Chief Resident and received the RSNA Roentgen Resident Research Award.

His philosophy of care is to empower patients with the knowledge, confidence, and support required to confront their disease.

Click here for more information about New York Proton Center’s Care Team.

Topics: |

PTCOG-NA Sixth Annual Conference October 14-16, 2019

Particle Therapy Cooperative Group North America will be holding its sixth annual conference October 14-16, 2019. It will be hosted by Miami Cancer Institute, a part of Baptist Health South Florida.

Please click here for more information.

Topics: |

Proton Collaborative Group (PCG) boosts its efforts to gather compelling clinical evidence on proton therapy

Warrenville, IL, September 22, 2017 – Proton Collaborative Group (PCG) is proud to announce the
start of a large-scale initiative to enhance its clinical data collection efforts in the field of
proton therapy. PCG currently houses the largest multi-institutional proton therapy patient
registry with over 10,000 patients from 12 treatment facilities across the U.S. included in its
database. PCG intends to expand its role in the collection of high quality data through the
implementation of a more robust database which is reviewed in on a going basis by an expert
International Data Steering Committee.
The enhanced database, “Alexandria”, will boost PCG’s registry to the next level. It will allow for
collection of more comprehensive data, by providing a platform for advanced dosimetry and imaging
data to be captured for all patients. This will greatly augment the current data entry and data
quality assurance efforts. Data collection will be quicker and more robust, allowing for better data

Click below to read the entire press release…

PCG press Release September 2017 FINAL

Topics: |

ASTRO Coverage Recommendations for Proton Beam Therapy

The use of proton beam therapy is somewhat controversial, owing to its high cost. The American Society for Radiation Oncology (ASTRO) has updated its recommendations for medical insurance coverage for this modality.

ASTRO’s policy paper provides guidance to all insurers, including Medicare, Medicaid, and commercial payers, about the clinical indications that are appropriate for proton bean therapy and that should be covered…

Read the full article at the link below:


Topics: |

Visit PCG at Booth #21 at the National Proton Conference in Orlando March 6-9th!

Topics: |

PCG Appoints Dr. Charles Simone as Chair of the PCG Executive Council

PCG is thrilled to announce that Charles Simone, MD, from the Maryland Proton Treatment Center, has been appointed as the Chairman of the PCG Executive Council. Dr. Simone currently serves as the chair of the PCG Lung Committee and will now also lead the Council’s efforts to provide oversight for all PCG committees, protocol development and approvals, clinical policies and procedures, and organizational strategy implementation. Congratulations Dr. Simone!


Topics: |